Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study

Ming Chia Lee, Chih Hsin Lee, Meng Rui Lee, Jann Yuan Wang, Shih Ming Chen

研究成果: 雜誌貢獻文章

摘要

Background: The protective effect of metformin against active tuberculosis (TB) among TB close contacts is unknown. Methods: TB close contacts with diabetes mellitus (DM) and normal renal function were selected from the National Health Insurance Research Database of Taiwan. Metformin users were patients who received ≥90 cumulative defined daily doses within 1 year before the index date. For each metformin user, a propensity-score matched metformin nonuser and an age- and sex-matched healthy TB close contact were selected. The outcome was incident TB, identified using previously validated diagnostic criteria. Independent predictors were investigated using stratified Cox regression analysis. Interaction analysis was also performed. Results: A total of 5846 TB close contacts who were metformin users, metformin non-users, and healthy contacts were analysed. The incidence of active TB was 755 (600-938), 1117 (927-1335), and 526 (393-689) cases per 100,000 person-years in each group, respectively. Multivariate analysis revealed that healthy contacts had the lowest risk of developing active TB (adjusted hazard ratio [aHR]: 0.42 [0.30-0.60]) and metformin use partially reversed the risk associated with DM (aHR: 0.73 [0.54-0.98]). Subpopulation analysis revealed a significant interaction between insulin use and metformin use. Conclusions: Metformin use is associated with a lower risk of developing active TB among TB close contacts with DM, especially for insulin users. It may be an alternative choice for primary prevention against active TB if no contraindications exist. However, prospective studies are needed to confirm the findings.
原文英語
文章編號936
期刊BMC Infectious Diseases
19
發行號1
DOIs
出版狀態已發佈 - 十一月 6 2019

指紋

Metformin
Diabetes Mellitus
Tuberculosis
Cohort Studies
Insulin
Propensity Score
National Health Programs
Primary Prevention
Taiwan
Multivariate Analysis
Regression Analysis
Databases
Prospective Studies
Kidney

ASJC Scopus subject areas

  • Infectious Diseases

引用此文

Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study. / Lee, Ming Chia; Lee, Chih Hsin; Lee, Meng Rui; Wang, Jann Yuan; Chen, Shih Ming.

於: BMC Infectious Diseases, 卷 19, 編號 1, 936, 06.11.2019.

研究成果: 雜誌貢獻文章

@article{145d65b0ee9f419dae55085a9824d851,
title = "Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study",
abstract = "Background: The protective effect of metformin against active tuberculosis (TB) among TB close contacts is unknown. Methods: TB close contacts with diabetes mellitus (DM) and normal renal function were selected from the National Health Insurance Research Database of Taiwan. Metformin users were patients who received ≥90 cumulative defined daily doses within 1 year before the index date. For each metformin user, a propensity-score matched metformin nonuser and an age- and sex-matched healthy TB close contact were selected. The outcome was incident TB, identified using previously validated diagnostic criteria. Independent predictors were investigated using stratified Cox regression analysis. Interaction analysis was also performed. Results: A total of 5846 TB close contacts who were metformin users, metformin non-users, and healthy contacts were analysed. The incidence of active TB was 755 (600-938), 1117 (927-1335), and 526 (393-689) cases per 100,000 person-years in each group, respectively. Multivariate analysis revealed that healthy contacts had the lowest risk of developing active TB (adjusted hazard ratio [aHR]: 0.42 [0.30-0.60]) and metformin use partially reversed the risk associated with DM (aHR: 0.73 [0.54-0.98]). Subpopulation analysis revealed a significant interaction between insulin use and metformin use. Conclusions: Metformin use is associated with a lower risk of developing active TB among TB close contacts with DM, especially for insulin users. It may be an alternative choice for primary prevention against active TB if no contraindications exist. However, prospective studies are needed to confirm the findings.",
keywords = "Close contact, Diabetes mellitus, Host-directed therapy, Metformin, Tuberculosis",
author = "Lee, {Ming Chia} and Lee, {Chih Hsin} and Lee, {Meng Rui} and Wang, {Jann Yuan} and Chen, {Shih Ming}",
year = "2019",
month = "11",
day = "6",
doi = "10.1186/s12879-019-4577-z",
language = "English",
volume = "19",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study

AU - Lee, Ming Chia

AU - Lee, Chih Hsin

AU - Lee, Meng Rui

AU - Wang, Jann Yuan

AU - Chen, Shih Ming

PY - 2019/11/6

Y1 - 2019/11/6

N2 - Background: The protective effect of metformin against active tuberculosis (TB) among TB close contacts is unknown. Methods: TB close contacts with diabetes mellitus (DM) and normal renal function were selected from the National Health Insurance Research Database of Taiwan. Metformin users were patients who received ≥90 cumulative defined daily doses within 1 year before the index date. For each metformin user, a propensity-score matched metformin nonuser and an age- and sex-matched healthy TB close contact were selected. The outcome was incident TB, identified using previously validated diagnostic criteria. Independent predictors were investigated using stratified Cox regression analysis. Interaction analysis was also performed. Results: A total of 5846 TB close contacts who were metformin users, metformin non-users, and healthy contacts were analysed. The incidence of active TB was 755 (600-938), 1117 (927-1335), and 526 (393-689) cases per 100,000 person-years in each group, respectively. Multivariate analysis revealed that healthy contacts had the lowest risk of developing active TB (adjusted hazard ratio [aHR]: 0.42 [0.30-0.60]) and metformin use partially reversed the risk associated with DM (aHR: 0.73 [0.54-0.98]). Subpopulation analysis revealed a significant interaction between insulin use and metformin use. Conclusions: Metformin use is associated with a lower risk of developing active TB among TB close contacts with DM, especially for insulin users. It may be an alternative choice for primary prevention against active TB if no contraindications exist. However, prospective studies are needed to confirm the findings.

AB - Background: The protective effect of metformin against active tuberculosis (TB) among TB close contacts is unknown. Methods: TB close contacts with diabetes mellitus (DM) and normal renal function were selected from the National Health Insurance Research Database of Taiwan. Metformin users were patients who received ≥90 cumulative defined daily doses within 1 year before the index date. For each metformin user, a propensity-score matched metformin nonuser and an age- and sex-matched healthy TB close contact were selected. The outcome was incident TB, identified using previously validated diagnostic criteria. Independent predictors were investigated using stratified Cox regression analysis. Interaction analysis was also performed. Results: A total of 5846 TB close contacts who were metformin users, metformin non-users, and healthy contacts were analysed. The incidence of active TB was 755 (600-938), 1117 (927-1335), and 526 (393-689) cases per 100,000 person-years in each group, respectively. Multivariate analysis revealed that healthy contacts had the lowest risk of developing active TB (adjusted hazard ratio [aHR]: 0.42 [0.30-0.60]) and metformin use partially reversed the risk associated with DM (aHR: 0.73 [0.54-0.98]). Subpopulation analysis revealed a significant interaction between insulin use and metformin use. Conclusions: Metformin use is associated with a lower risk of developing active TB among TB close contacts with DM, especially for insulin users. It may be an alternative choice for primary prevention against active TB if no contraindications exist. However, prospective studies are needed to confirm the findings.

KW - Close contact

KW - Diabetes mellitus

KW - Host-directed therapy

KW - Metformin

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=85074626033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074626033&partnerID=8YFLogxK

U2 - 10.1186/s12879-019-4577-z

DO - 10.1186/s12879-019-4577-z

M3 - Article

C2 - 31694558

AN - SCOPUS:85074626033

VL - 19

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 936

ER -